FDA Class II · Drug · April 29, 2026
Furosemide Tablets recall — Leading Pharma, LLC
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
Official ID D-0486-2026 · Official record ↗
1 recent recall on record for Leading Pharma in CPSC, NHTSA, and FDA data as of July 24, 2026 at 1:09 AM UTC.
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
Official ID D-0486-2026 · Official record ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked July 24, 2026 at 1:09 AM UTC.